Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirum Pharmaceuticals, Inc.

43.23
-1.7700-3.93%
Post-market: 43.230.00000.00%19:50 EDT
Volume:464.32K
Turnover:20.19M
Market Cap:2.12B
PE:-23.36
High:44.99
Open:44.86
Low:43.13
Close:45.00
Loading ...
Jun 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 06, 2022

Major Issues Report

8-K - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 09, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Nov 19, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 29, 2021

Major Issues Report

8-K - Current report
Aug 24, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 20, 2021

Major Issues Report

8-K - Current report